Levels of serum hyaluronic acid, TNF-α and IL-8 in patients with nonalcoholic steatohepatitis

Hepato-Gastroenterology

Volumn 52, Issue 65, 2005, Pages 1549-1553

  Bahcecioglu, Ibrahim Halil ^a   Yalniz, Mehmet ^a   Ataseven, Huseyin ^a   Ilhan, Necip ^a   Ozercan, Ibrahim Hanifi ^a,b   Seckin, Dilara ^a   Sahin, Kazim ^a,b  

^a FIRAT UNIVERSITY   (Turkey)

^b Faculty of Science   (Turkey)

Author keywords

Histopathology; Hyaluronic acid; Interleukin 8; Nonalcoholic steatohepatitis; TNF

Indexed keywords

HYALURONIC ACID; INTERLEUKIN 8; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LIVER BIOPSY; LIVER CIRRHOSIS; LIVER FIBROSIS; MALE; NONALCOHOLIC FATTY LIVER; PRIORITY JOURNAL;

ADULT; BODY MASS INDEX; FATTY LIVER; FEMALE; HEPATITIS; HUMANS; HYALURONIC ACID; INTERLEUKIN-8; LIVER CIRRHOSIS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 25844508967     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Harrison SA, Kadakia S, Lang K, Schenker S: Nonalcoholic steatohepatitis: What we know in the new millennium. Am J Gastroenterol 2002; 97:2714-2724.
2. Kumar KS, Malet PF: Nonalcoholic steatohepatitis. Mayo Clin Proc 2000; 75:733-739.
3. Sanyal AJ: American Gastroenterological Association. AGA technical review on nonalcoholic fatty liver disease. Gastroenterology 2002; 12:1705-1725.
4. James OF, Day CP: Non-alcoholic steatohepatitis (NASH): a disease of emerging identity and importance. J Hepatol 1998; 29:495-501.
5. Sheth SG, Gordon FD, Chopra S: Nonalcoholic steatohepatitis. Ann Intern Med 1997; 15(126):137-145.
6. Ludwig J, Vaggiano TR, McGill DB, Ott BJ: Non-alcoholic steatohepatitis: Mayo Clinic Experiences with hiherto unnamed disease. Mayo Clin Proc 1980; 55:434-438.
7. Alba LM, Lindor K: Review article: Non-alcoholic fatty liver disease. Aliment Pharmacol Ther 2003; 17:977-986.
8. Angulo P, Keabh JC, Batts KP, et al: Independent predictors of liver fibrosis in patients with non-alcoholic steatohepatitis. Hepatology 1999; 30:1356-1362.
9. Ratziu Y, Giral P, Charlotte F, et al: Liver fibrosis in overweight patients. Gastroenterology 2000; 118:1117-1123.
10. Engstrom-Laurent A: Changes in hyaluronan concentration in tissues and body fluids in disease state. In: The Biology of hyaluronan, Ciba Foundation Symposium. Chichester, England: Wiley, 1989; pp. 233-247.
11. Eriksson S, Fraser JRE, Pertoft H, Smedsrod B: Endothelial cells are a site of uptake and degradation of hyaluronic acid in the liver. Exp Cell Res 1983; 144:223-228.
12. Smedsrod B, Pertoft H, Eriksson S, Fraser RE, Laurent TC: Studies in vitro on the uptake and degradation of sodium hyaluronate in rat liver endothelial cells. Biochem J 1984; 222:617-626.
13. Köpke-Aguiar LA, Martins JRM, Passerotti CC, Toledo CF, Nader HB, Borges DR: Serum hyaluronic acid as a comprehensive marker to assess severity of liver disease in schistosomiasis. Acta Tropica 2002; 84:117-126.
14. Patel K, Lajoie A, Heaton S, Pianko S, Behling CA, Bylund D, Pockros P, Blatt LM, Conrad A, McHutchinson JG: Clinical use of hyaluronic acid as a predictor of fibrosis change in hepatitis C. J Gastroenterol Hepatol 2003; 18:253-257.
15. Wong VS, Hughes V, Trull A, Wight DG, Petrik J, Alexander GJ: Serum hyaluronic acid a useful marker of liver fibrosis in chronic hepatitis C infection. J Viral Hepat 1998; 5:187-192.
16. Pontinha N, Pessequeiro H, Barros H: Serum hyaluronan as a marker of liver fibrosis in a symptomatic chronic viral hepatitis B. Scand J Clin Lab Invest 1999; 59:343-347.
17. Tilg H, Diehl AM: Cytokines in alcoholic and nonalcoholic steatohepatitis. N Engl J Med 2000; 343:1467-1476.
18. Day CP: Pathogenesis of steatohepatitis. Best Pract Res Clin Gastroenterol 2002; 16:663-678.
19. Bonora E, Targher G, Alberiche M, Bonadonna RC, Saggiani F, Zenere MB, Monauni T, Muggeo M: Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: studies in subjects with various degrees of glucose tolerance and insulin sensitivity. Diabetes Care 2000; 23:57-63.
20. Crespo J, Cayon A, Fernandez-Gil P, Hernandez-Guerra M, Mayorga M, Dominguez-Diez A, Fernandez-Escalante JC, Pons-Romero F: Gene expression of tumor necrosis factor alpha and TNF-receptors, p55 and p75, in nonalcoholic steatohepatitis patients. Hepatology 2001; 34:1158-1163.
21. Angulo P: Nonalcoholic fatty liver disease. N Engl J Med 2002; 346(16):1221-1231.
22. Kugelmas M, Hill DB, Vivian B, Marsano L, McClain CJ: Cytokines and NASH: a pilot study of the effects of lifestyle modification and vitamin E. Hepatology 2003; 38:413-419.
23. Brunt EM, Janney CG, Di Bisceglie AM, Neuschwander-Tetri BA, Bacon BR: Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions. Am J Gastroenterol 1999; 94:2467-2474.
24. Stickel F, Gudrun P, Schuppan D, et al: Serum hyaluronate correlates with histological progression in alcoholic liver disease. Eur J Gastroenterol Hepatol 2003; 15:941-944.
25. Suehiro T, Boros P, Emre S, et al: Assessment of liver function by hyaluronic acid and endothelin levels. J Surg Res 1997; 73:123-128.
26. Guerchot J, Sefaty L, Bonnand AM, et al: Prognostic value of serum hyaluronan in patients with compensated HCV cirrhosis. J Hepatol 2000; 32:447-452.
27. Guechot J, Loria A, Serfaty L, et al: serum hyaluronan as a marker of liver fibrosis in chronic viral hepatitis C: effect of alpha-interferon therapy. J Hepatol 1995; 22:22-26.
28. Kaplan LM: Leptin, obesity, and liver disease. Gastroenterology 1998; 115:997-1001.
29. Kern PA, Saghizadeh M, Ong JM, et al: The expression of tumor necrosis factor in human adipose tissue. Regulation of obesity, weight loss, and relationship to lipoprotein lipase. J Clin Lab Invest 1995; 95:2111-2119.
30. Williams AM, Langley PG, Osei-Hwediah J, Wendon JA, Hughes RD: Hyaluronic acid and endothelial damage due to paracetamol-induced hepatotoxicity. Liver 2003; 23:110-115.